December 2025 – March 2026
Characterizing the Quality of Evidence-based Prescribing for Hospitalized Veterans
VA Merit Award I01 RD000382 First VA Merit Award
Start Date: January 1, 2026
End Date: December 31, 2029
Discovering WNK body condensate interactions in the kidney
Dialysis Clinic, Inc. C- 4234
Start Date: January 1, 2026
End Date: December 31, 2026
Total Costs: $100,000
Epigenetic Regulation of Hypothalamic Energy Homeostasis
R01DK145725 First R01
Start Date: March 18, 2026
End Date: January 31, 2031
Total Annual Costs: $664,240
Coupling lysosomal and mitochondrial lipid metabolism in adipose tissue macrophages as a therapeutic strategy in obesity
American Diabetes Association
Start Date: January 1, 2026
End Date: December 31, 2028
Total Costs: $88,428
Jana Jacobs, PhD // Infectious Diseases
Jan Biotech JBI-PITT-AI-2026-Y1
Start Date: February 1, 2026
End Date: July 31, 2026
Total Costs: $60,730
Emily Kinney (Mike Lab) // Infectious Diseases
Investigating Klebsiella pneumoniae Mucoidy in Bloodstream Infections
American Heart Association Predoctoral Fellowship
Start Date: January 1, 2026
End Date: December 31, 2027
Total Costs: $70,676
Robert Lafyatis, MD // Rheumatology and Clinical Immunology
IL-6 regulation of the CCL18 basic helix-loop-helix enhancer in profibrotic macrophages in sclerodermainterstitial lung disease
World Scleroderma Foundation
Start Date: February 1, 2026
End Date: August 31, 2027
Total Costs: $175,182
Minh-Hong Nguyen, MD // Infectious Diseases
Candida glabrata populations during gastrointestinal tract colonization and abdominal candidiasis
R21 AI197082
Start Date: February 1, 2026
End Date: January 31, 2028
Total Costs: $437,250
Minh-Hong Nguyen, MD // Infectious Diseases
Unrecognized azole resistance among Candida parapsilosis causing bloodstream infections
R21 AI191005
Start Date: February 1, 2026
End Date: January 31, 2028
Total Costs: $437,250
Joseph Pilewski, MD // Pulmonary, Allergy, Critical Care, and Sleep Medicine
CF Lung Transplant Initiative Leadership Award
Cystic Fibrosis Foundation
Start Date: January 1, 2026
End Date: December 31, 2028
Total Costs: $57,375
Thomas Radomski, MD, MS // General Internal Medicine
Humana SRA00006268
Start Date: February 4, 2026
End Date: February 3, 2029
Total Costs: $87,314
Daniella Schwartz, MD // Rheumatology and Clinical Immunology
Mechanistic Advances in TNFAIP3 and A20 Immunity
Jeffrey Modell Foundation
Start Date: January 1, 2026
End Date: December 1, 2027
Total Costs: $100,000
Kenneth Smith, MD, MS // General Internal Medicine
Pneumococcal vaccination cost-effectiveness analyses
Merck & Co. Inc. SRA00006230
Start Date: January 12, 2026
End Date: January 11, 2028
Total Costs: $562,390
Adeline Supandy, PhD (Van Tyne Lab) // Infectious Diseases
Antibiotic Exposure Drives Adaptations Linked to Bloodstream Infection in Vancomycin-Resistant Enterococcus Faecium
American Heart Association Postdoctoral Fellowship
Start Date: January 1, 2026
End Date: December 31, 2027
Total Costs: $159,160
Jeremy Tilstra, MD, PhD // Rheumatology and Clinical Immunology
CAB201002: A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologuous CD19 Specific Chimeric Antigen Receptor T cells (CABA-201) in Subjects with Active Cabaletta Bio, Inc. SRA00006587
Start Date: February 9, 2026
Total Costs: $601,709
Daria Van Tyne, PhD, and Ryan Shields, PharmD // Infectious Diseases
A rationally designed phage cocktail to treat MDR P. aeruginosa infections
R21 AI191407
Start Date: February 4, 2026
End Date: January 31, 2028
Total Costs: $437,250
Kristin Wannemo (Königshoff Lab) // Pulmonary, Allergy, Critical Care, and Sleep Medicine
AMOTL2 deficiency as a driver of lung fibrosis
American Heart Association Predoctoral Fellowship
Start Date: January 1, 2026
End Date: December 31, 2027
Total Costs: $70,676
Qi Yu, PhD // Cardiology/Vascular Medicine Institute
The Role of NIPBL in Human iPSC-Derived Cardiomyocyte Differentiation
American Heart Association Postdoctoral Fellowship
Start Date: January 1, 2026
End Date: December 31, 2027
Total Costs: $80,840
Anna Zemke, MD, PhD // Pulmonary, Allergy, Critical Care, and Sleep Medicine
2025 Program for Adult Care Excellence
Cystic Fibrosis Foundation
Start Date: December 1, 2025
End Date: November 30, 2028
Total Costs: $43,047
Internal Funding Opportunities
McKamish Family Foundation Cardiology Innovator Awards
The McKamish Family Foundation Cardiology Innovator Awards are made possible through a generous donation from the McKamish Family Foundation that began in December 2021. The goal of these awards is to advance innovative clinical and translational cardiovascular research in the Cardiology Division of the University of Pittsburgh Medical Center with the goal of conducting research that would lead to extramural funding of clinical trials and/or population studies
Who: Project must be a study whose principal investigator is a faculty member in HVI-Cardiology
What: Up to $25K, one-year seed funding for an innovative clinical or translational project with strong potential to lead to extramural funding. There will be an opportunity to receive a second installment of $25K, based on progress, promising results, and appropriate budgetary justification. Up to 6 applications will be funded annually.
Details and application: vmi.pitt.edu/funding/innovator-awards
The submission deadline is May 8, 2026.
Pitt Idea Navigation to Commercialization (Pitt.INC)
A pre-invention disclosure funding opportunity designed to generate proof-of-principle data for novel ideas with high commercial potential. With awards of up to $50,000, the program supports projects from Pitt’s Schools of the Health Sciences addressing unmet needs or challenges in human health and disease.
Applications are accepted on a rolling basis. >> Learn more and apply to Pitt.INC.